Novartis AG
Novartis AG (NVSEF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NVSEF · as of Jun 8, 2026
Key Statistics
Explore Novartis AG Data
nvsef stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 20 · Buy rate: 25.0%
Competitors & Peers
nvsef competitorsNVSEF
AZNCF
CHGCF
FSNUY
GLAXF
NONOFStock Performance
Full HistoryAbout Novartis AG
Novartis AG a global pharmaceutical enterprise established in 1996 and based in Basel, Switzerland, is engaged in the entire lifecycle of healthcare products, from research and development to manufac…
what is novartis ag · nvsef stock overview · novartis ag company profile · who is novartis ag ceo · nvsef OTC · novartis ag headquarters · novartis ag business segments
About Stock Overview & Key Data
Novartis AG (NVSEF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Apr 26, 2010. As of the latest trading session, NVSEF stock price is $148.80, with a market capitalization of $283.9B. The stock has returned +26.53% over the past 12 months and +7.83% year-to-date.
According to 20 Wall Street analysts, the consensus rating for Novartis AG stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Novartis AG reported revenue of $57.1B and net income of $14.6B. For detailed data — including Novartis AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Novartis AG (NVSEF) stock price is $148.80. The stock is traded on OTC under the ticker symbol NVSEF. The 52-week range is $110.74 – $171.29.